Phenanthrenes: A Promising Group of Plant Secondary Metabolites

• Published in: Journal of natural products (Washington, D.C.) Vol. 81; no. 3; pp. 661 - 678
• Main Authors: Tóth, Barbara, Hohmann, Judit, Vasas, Andrea
• Format: Journal Article
• Language: English
• Published: United States American Chemical Society and American Society of Pharmacognosy 23-03-2018
• ISSN: 0163-3864; 1520-6025
• DOI: 10.1021/acs.jnatprod.7b00619

Although phenanthrenes are considered to constitute a relatively small group of natural products, discovering new phenanthrene derivatives and evaluating their prospective biological activities have become of great interest to many research groups worldwide. Based on 160 references, this review covers the phytochemistry and pharmacology of 213 naturally occurring phenanthrenes that have been isolated between 2008 and 2016. More than 40% of the 450 currently known naturally occurring phenanthrenes were identified during this period. The family Orchidaceae is the most abundant source of these compounds, although several new plant families and genera have been involved in the search for phenanthrenes. The presence of certain substituent patterns may be restricted to specific families; vinyl-substituted phenanthrenes were reported only from Juncaceae plants, and prenylated derivatives occur mainly in Euphorbiaceae species. Therefore, these compounds also can serve as chemotaxonomic markers. Almost all of the newly isolated compounds have been studied for their biological activities (e.g., potential cytotoxic, antimicrobial, anti-inflammatory, and antioxidant effects), and many of them showed multiple activities. According to the accumulated data, denbinobin, with a novel mechanism of action, has great potential as a lead compound for the development of a new anticancer agent.